Area of research
Epidemiology · Infectious Diseases
Research interest
Research interests include Cytomegalovirus and herpesvirus research, SARS-CoV-2 and COVID-19 Research, Respiratory viral infections research, and Hepatitis C virus research.
Repurposing Licensed Drugs with Activity Against Epstein–Barr Virus for Treatment of Multiple Sclerosis: A Systematic Approach
Affinity maturation endows potent activity onto class 6 SARS-CoV-2 broadly neutralizing antibodies
Clinical, Genomic, and Immunological Characterization of RSV Surge in Sydney, Australia, 2022
Emergence and antibody evasion of BQ, BA.2.75 and SARS-CoV-2 recombinant sub-lineages in the face of maturing antibody breadth at the population level
Enteroviruses and risk of islet autoimmunity or type 1 diabetes: systematic review and meta-analysis of controlled observational studies detecting viral nucleic acids and proteins
Broadly neutralizing SARS-CoV-2 antibodies through epitope-based selection from convalescent patients
Vaccine value profile for cytomegalovirus
Global disparities in SARS-CoV-2 genomic surveillance
RSV Epidemiology in Australia Before and During COVID-19
Platform for isolation and characterization of SARS-CoV-2 variants enables rapid characterization of Omicron in Australia
Maintenance of broad neutralizing antibodies and memory B cells 1 year post-infection is predicted by SARS-CoV-2-specific CD4+ T cell responses
Tracking the international spread of SARS-CoV-2 lineages B.1.1.7 and B.1.351/501Y-V2 with grinch
Tracking the international spread of SARS-CoV-2 lineages B.1.1.7 and B.1.351/501Y-V2
SARS-CoV-2 neutralizing antibodies: Longevity, breadth, and evasion by emerging viral variants
Long-term persistence of RBD+ memory B cells encoding neutralizing antibodies in SARS-CoV-2 infection
Respiratory viral co-infections among SARS-CoV-2 cases confirmed by virome capture sequencing
Genomics-informed responses in the elimination of COVID-19 in Victoria, Australia: an observational, genomic epidemiological study
Immunizations with diverse sarbecovirus receptor-binding domains elicit SARS-CoV-2 neutralizing antibodies against a conserved site of vulnerability
Viruses and Type 1 Diabetes: From Enteroviruses to the Virome
Analytical validity of nanopore sequencing for rapid SARS-CoV-2 genome analysis
IFCC Interim Guidelines on Serological Testing of Antibodies against SARS-CoV-2
IFCC Interim Guidelines on Molecular Testing of SARS-CoV-2 Infection
IFCC Interim Guidelines on Biochemical/Hematological Monitoring of COVID-19 Patients
Performance of the Alethia CMV Assay for Detection of Cytomegalovirus by Use of Neonatal Saliva Swabs
Early-life factors contributing to type 1 diabetes
Knowledge of congenital cytomegalovirus (CMV) in pregnant women in Australia is low, and improved with education
Higher abundance of enterovirus A species in the gut of children with islet autoimmunity
Infectious Disease Transmission in Solid Organ Transplantation: Donor Evaluation, Recipient Risk, and Outcomes of Transmission
Systematic review of the impact of point‐of‐care testing for influenza on the outcomes of patients with acute respiratory tract infection
Maternal virus infections in pregnancy and type 1 diabetes in their offspring: Systematic review and meta‐analysis of observational studies